• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT LIBRARY
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System

September 10, 2025 By SPINEMarketGroup

WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System (“VerteGlide”), used to treat Early Onset Scoliosis (“EOS”).

Dr. Richard McCarthy, a pediatric orthopedic spine surgeon in Louisville, Kentucky who, along with Dr. Kent Walker, performed one of the first procedures shared, “The first procedures with VerteGlide were a great success. For these patients, there is a very limited set of options, and this breakthrough growth guidance system offers a solution for a significant unmet clinical need. This technology will greatly benefit the first patients and many other kids in the future. OrthoPediatrics should feel very proud of the work put into creating this device for the benefit of children”.

As part of OrthoPediatrics’ Scoliosis suite of products, VerteGlide provides another unique alternative for the treatment of scoliosis that leverages advanced implant and instrument technology. VerteGlide is a unique Scoliosis deformity correction system for early onset scoliosis patients that exhibit some of the most complex spinal pathology. In addition, VerteGlide will be featured at the upcoming 60th Annual Meeting of the Scoliosis Research Society in September, and the 19th International Congress on Early Onset Scoliosis meeting in November.

OrthoPediatrics Scoliosis division President, Greg Odle commented, “By leveraging the knowledge of a first-class surgeon design team that has the most practical knowledge of pediatric spinal growth guidance concepts, this system offers surgeons a unique ability to treat EOS by addressing the most diseased areas of the spinal column. The complex nature of EOS demands that surgeons have access to the most cutting-edge technology available. We are pleased to offer the most advanced system on the market and to see the success of the first procedures.”

The VerteGlide Spinal Growth Guidance System is made possible with the Shilla™ technology licensed from Medtronic.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937- 5406

Filed Under: NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMMED
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
logo paradigm spine

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • BROCHURES
  • PRODUCT LIBRARY
  • Expandable cages were adopted not because they fused…
  • Medical Device Correction Addresses Loss of Lordosis…
  • Who Is Really Winning the Mid-Tier Spine…
  • Medtronic Named in Florida Lawsuit Over Alleged…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Johnson & Johnson Explores Potential $20B Sale…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • Medtronic receives FDA clearance for Stealth AXiS™…
  • Why Expandable Cages Sometimes Lose Lordosis After…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Medtronic Korea Launches Kanghui, a New…
  • Globus Medical Reports Fourth Quarter and Full Year…
  • Most Spine Failures Are Predictable — The Bone…
  • Behind the Deal: The Strategic Logic of Zavation’s…
  • 2025 Spine Product Launches and Trends: Where is the…
  • What Is Medtronic’s PILAR™ Technique?
  • From Niche to Momentum: The Rapid Rise of Spinal…
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • From Early Innovations to Modern Practice: Where Are…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • Single-Use Spine Surgery Systems: The Future or…
  • VB Spine Announces Successful First Clinical Cases…
  • Loyalty in the Spine Industry: Real, Valuable… and…
  • LAST 5 VIDEOS PUBLISHED

    1. SI-BONE: iFuse INTRA Ti™ Implant System
    2. Globus Medical: IntraLIF™ Cannulated
    3. SI-BONE: iFuse TORQ TNT® Implant System
    4. Globus Medical: VICTORY™ Lumbar Plate
    5. Alphatec Spine: ASCEND™ VBR 12mm

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal

    Copyright © 2026 · SPINEMarketGroup